The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.
Launched by UNIVERSITY OF NORTH CAROLINA, GREENSBORO · Oct 8, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Public or private Bahraini middle or high school students.
- • In addition to the main evaluation questions, the following groups will also be included to make programmatic improvements.
- • Parents of above mentioned middle or high school students.
- • D.A.R.E. Officers teaching middle school and high school D.A.R.E. in Bahrain.
- Exclusion Criteria:
- • None
About University Of North Carolina, Greensboro
The University of North Carolina at Greensboro (UNCG) is a distinguished institution committed to advancing knowledge through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UNCG leverages its robust academic resources and expert faculty to conduct high-quality clinical studies aimed at improving health outcomes. The university fosters a dynamic environment that encourages the exploration of diverse medical and psychological interventions, ensuring that research efforts are aligned with the needs of the community and contribute to the broader field of healthcare. Through its dedication to rigorous scientific inquiry and ethical standards, UNCG plays a pivotal role in translating research findings into practical solutions for real-world challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Greensboro, North Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials